STRIVERDI RESPIMAT 2.5 MCG
OLODATEROL (OLODATEROL HYDROCHLORIDE) : 2.5 MCG · DIN 02407868 · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada status: CANCELLED PRE MARKET
What is STRIVERDI RESPIMAT?
STRIVERDI RESPIMAT 2.5 MCG contains OLODATEROL (OLODATEROL HYDROCHLORIDE) : 2.5 MCG. It is listed in the Health Canada Drug Product Database under DIN 02407868, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as SOLUTION for INHALATION administration. Health Canada currently lists it as cancelled pre market, status dated 10-Nov-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is STRIVERDI RESPIMAT used for?
Long-term, once daily maintenance bronchodilator treatment of airflow obstruction in patients with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02407868 |
|---|---|
| Brand name | STRIVERDI RESPIMAT |
| Generic / active ingredient | OLODATEROL (OLODATEROL HYDROCHLORIDE) : 2.5 MCG |
| Manufacturer | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Strength | 2.5 MCG |
| Dosage form | SOLUTION |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03AC19 OLODATEROL |
| AHFS class | 12:12.08.12 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 10-Nov-2021 |
How is it administered?
Recommended dose: 5 mcg (two puffs of 2.5 mcg) once daily at the same time of day. For oral inhalation only. Not for acute symptoms.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in the provided text snippet (refer to page 18 of full monograph).
How is it supplied?
Cartridge for use only with the STRIVERDI RESPIMAT inhaler. (Specific bottle/pack sizes not detailed in provided text).
Contraindications
Hypersensitivity to olodaterol or excipients. All LABAs are contraindicated in asthma patients without use of a long-term asthma control medication. Not indicated for asthma.
Warnings and precautions
LABAs increase risk of asthma-related death. Not for acute bronchospasm. Caution in cardiovascular disorders, convulsive disorders, thyrotoxicosis, and hypokalemia. Paradoxical bronchospasm risk.
Who else supplies OLODATEROL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OLODATEROL appears in 14 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.